What is Zacks Research’s Estimate for IRWD Q1 Earnings?
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, February 12th. Zacks Research analyst R. Department now anticipates that the biotechnology company will earn $0.01 per share for the quarter, down from their prior forecast […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, February 12th. Zacks Research analyst R. Department now anticipates that the biotechnology company will earn $0.01 per share for the quarter, down from their prior forecast […]
